FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileMedicus Pharma Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MDCXW
Medicus Pharma Ltd. Stock AnalysisComprehensive stock analysis for Medicus Pharma Ltd. (MDCXW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisMDCXW
MDCXW
Medicus Pharma Ltd.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
MDCXW
  1. Home
  2. Stocks
  3. Medicus Pharma Ltd.

Medicus Pharma Ltd.

🇺🇸MDCXW•NASDAQ

Medicus Pharma Ltd.

🇺🇸MDCXW•NASDAQ
Market cap
$2.58M

Your view on MDCXW

Mkt Cap
$2.58M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Medicus Pharma Ltd.

Industry
Biotechnology
Sector
Healthcare
CEO
Raza Bokhari
Headquarters
300 Conshohocken State Road, Conshohocken, PA, CA
Industry
Biotechnology
Sector
Healthcare
CEO
Raza Bokhari
Headquarters
300 Conshohocken State Road, Conshohocken, PA, CA
Description

Medicus Pharma Ltd. is a biotech life sciences company, which focuses on accelerating the clinical development programs of novel and disruptive therapeutic assets. It develops a product, SkinJectTM, with an indication for basal cell carcinoma. The company was founded on April 30, 2008 and is headquartered in Toronto, Canada.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Medicus Pharma Ltd.. Starting points for Medicus Pharma Ltd.: EPS -$33.76, beta -0.65 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Medicus Pharma Ltd.. Trailing twelve-month EPS for Medicus Pharma Ltd. stands at -$33.76. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Wall Street analysts· not FRC research
Nov 22, 2026
More →

Earnings per share estimates

Per shareThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate−$4.44−$0.23−$33.95−$15.15
Lowest estimate−$4.44−$0.23−$33.95−$15.15
Highest estimate−$4.44−$0.23−$33.95−$15.15
Number of analysts1111
A year ago−$0.511−$0.311−$98.001—
Growth vs a year ago————

1The year-ago figure includes one-time items, so growth is not shown.

Revenue estimates

TotalThis quarterDec 2026Next quarterMar 2027This yearYear to Dec 2026Next yearYear to Dec 2027
Average estimate$0.00$0.00$49440.00$0.00
Lowest estimate$0.00$0.00$49440.00$0.00
Highest estimate$0.00$0.00$49440.00$0.00
Number of analysts0040
A year ago$0.00$0.00$0.00—
Growth vs a year ago————

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Medicus Pharma Ltd.. Medicus Pharma Ltd. has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold MDCXW19 companies
Compare MDCXW with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustryMkt cap
CUECue Biopharma, Inc.HealthcareBiotechnology$34.7M
FBIOFortress Biotech, Inc.HealthcareBiotechnology$63.4M
HOWLWerewolf Therapeutics, Inc.HealthcareBiotechnology$46.0M
ICCCImmuCell CorporationHealthcareBiotechnology$99.3M
INKTMiNK Therapeutics, Inc.HealthcareBiotechnology$41.2M
NRXPNRx Pharmaceuticals, Inc.HealthcareBiotechnology$95.3M
OSTXOS Therapies IncorporatedHealthcareBiotechnology$42.0M
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BLAB.CNBritannia Life Sciences Inc.HealthcareCNQ$13.0M
BLEGBranded Legacy IncHealthcareOTC$542,622
BLRXBioLineRx Ltd.HealthcareNASDAQ$4.8M
BLSMBlossomHill Therapeutics, Inc.HealthcareNASDAQ$422.0M
BLTEBelite Bio, IncHealthcareNASDAQ$5.2B
BMEABiomea Fusion, Inc.HealthcareNASDAQ$41.7M
BMNDFBiomind Labs Inc.HealthcareOTC$8.8M
BMRNBioMarin Pharmaceutical Inc.HealthcareNASDAQ$11.7B
BNIGFBeroni Group LimitedHealthcareOTC$220,063
BNTCBenitec Biopharma Inc.HealthcareNASDAQ$285.9M
BNTXBioNTech SEHealthcareNASDAQ$20.1B
BOLDBoundless Bio, Inc.HealthcareNASDAQ$54.8M
Open Comparable Analysis
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Medicus Pharma Ltd. executives and directors. Shares of Medicus Pharma Ltd. have traded between $0.44 and $2.50 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Medicus Pharma Ltd.

MDCXW AnalysisWeak
Past
1
Growth
2
Health
1
Profit
1
Value
1